APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Basal Insulin (Long-Acting Insulin)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Basal Insulin (Long-Acting Insulin) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173969290320 December 2025187 pages

Choose your research edition.

Industry ResearchBasal Insulin (Long-Acting Insulin) Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Basal Insulin (Long-Acting Insulin) Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Basal Insulin (Long-Acting Insulin) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Basal Insulin (Long-Acting Insulin) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Basal Insulin (Long-Acting Insulin) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Basal Insulin (Long-Acting Insulin) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Basal Insulin (Long-Acting Insulin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Basal Insulin (Long-Acting Insulin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Basal Insulin (Long-Acting Insulin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Basal Insulin (Long-Acting Insulin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Basal Insulin (Long-Acting Insulin) include Wockhardt, Eli Lilly, Julphar, Sedico, Sanofi Aventis, Novo Nordisk, Exir and Biocon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Basal Insulin (Long-Acting Insulin) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Basal Insulin (Long-Acting Insulin) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Basal Insulin (Long-Acting Insulin) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Basal Insulin (Long-Acting Insulin) market size, projected growth trends, production technologies, key applications, and end-use industries.

Basal Insulin (Long-Acting Insulin) Segment by Company

Wockhardt

Eli Lilly

Julphar

Sedico

Sanofi Aventis

Novo Nordisk

Exir

Biocon

Basal Insulin (Long-Acting Insulin) Segment by Type

Basaglar

Lantus

Levemir

Biosimilar Glargines

Toujeo

Tresiba

Basal Insulin (Long-Acting Insulin) Segment by Application

Type 1 Diabetes

Type 2 Diabetes

Basal Insulin (Long-Acting Insulin) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Basal Insulin (Long-Acting Insulin) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Basal Insulin (Long-Acting Insulin) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Basal Insulin (Long-Acting Insulin).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Basal Insulin (Long-Acting Insulin) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Basal Insulin (Long-Acting Insulin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Basal Insulin (Long-Acting Insulin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Basal Insulin (Long-Acting Insulin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Basal Insulin (Long-Acting Insulin) Industry Trends Table 2. Basal Insulin (Long-Acting Insulin) Industry Drivers Table 3. Basal Insulin (Long-Acting Insulin) Industry Opportunities and Challenges Table 4. Basal Insulin (Long-Acting Insulin) Industry Restraints Table 5. Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Basal Insulin (Long-Acting Insulin) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Manufacturers Table 9. Global Basal Insulin (Long-Acting Insulin) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Basal Insulin (Long-Acting Insulin) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Basal Insulin (Long-Acting Insulin) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Basal Insulin (Long-Acting Insulin) Manufacturers, Product Type & Application Table 13. Global Basal Insulin (Long-Acting Insulin) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Basal Insulin (Long-Acting Insulin) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Basaglar Table 17. Major Manufacturers of Lantus Table 18. Major Manufacturers of Levemir Table 19. Major Manufacturers of Biosimilar Glargines Table 20. Major Manufacturers of Toujeo Table 21. Major Manufacturers of Tresiba Table 22. Global Basal Insulin (Long-Acting Insulin) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2026) & (K Units) Table 24. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2027-2032) & (K Units) Table 25. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2021-2026) Table 26. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2027-2032) Table 27. Global Basal Insulin (Long-Acting Insulin) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2026) & (K Units) Table 29. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2027-2032) & (K Units) Table 30. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2021-2026) Table 31. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Type 1 Diabetes Table 33. Major Manufacturers of Type 2 Diabetes Table 34. Global Basal Insulin (Long-Acting Insulin) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2026) & (K Units) Table 36. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2027-2032) & (K Units) Table 37. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2021-2026) Table 38. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2027-2032) Table 39. Global Basal Insulin (Long-Acting Insulin) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2026) & (K Units) Table 41. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2027-2032) & (K Units) Table 42. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2021-2026) Table 43. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2027-2032) Table 44. Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2021-2026) & (K Units) Table 46. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Region (2021-2026) Table 47. Global Basal Insulin (Long-Acting Insulin) Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Basal Insulin (Long-Acting Insulin) Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Basal Insulin (Long-Acting Insulin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2026) & (K Units) Table 51. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2027-2032) & (K Units) Table 52. Europe Basal Insulin (Long-Acting Insulin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2026) & (K Units) Table 54. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2027-2032) & (K Units) Table 61. Global Basal Insulin (Long-Acting Insulin) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2021-2026) Table 65. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2027-2032) Table 66. Wockhardt Company Information Table 67. Wockhardt Business Overview Table 68. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolio Table 70. Wockhardt Recent Development Table 71. Eli Lilly Company Information Table 72. Eli Lilly Business Overview Table 73. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolio Table 75. Eli Lilly Recent Development Table 76. Julphar Company Information Table 77. Julphar Business Overview Table 78. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Julphar Basal Insulin (Long-Acting Insulin) Product Portfolio Table 80. Julphar Recent Development Table 81. Sedico Company Information Table 82. Sedico Business Overview Table 83. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sedico Basal Insulin (Long-Acting Insulin) Product Portfolio Table 85. Sedico Recent Development Table 86. Sanofi Aventis Company Information Table 87. Sanofi Aventis Business Overview Table 88. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolio Table 90. Sanofi Aventis Recent Development Table 91. Novo Nordisk Company Information Table 92. Novo Nordisk Business Overview Table 93. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolio Table 95. Novo Nordisk Recent Development Table 96. Exir Company Information Table 97. Exir Business Overview Table 98. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Exir Basal Insulin (Long-Acting Insulin) Product Portfolio Table 100. Exir Recent Development Table 101. Biocon Company Information Table 102. Biocon Business Overview Table 103. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Biocon Basal Insulin (Long-Acting Insulin) Product Portfolio Table 105. Biocon Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Basal Insulin (Long-Acting Insulin) Distributors List Table 109. Basal Insulin (Long-Acting Insulin) Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Basal Insulin (Long-Acting Insulin) Product Image Figure 2. Global Basal Insulin (Long-Acting Insulin) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Basal Insulin (Long-Acting Insulin) Market Size (2021-2032) & (US$ Million) Figure 4. Global Basal Insulin (Long-Acting Insulin) Sales (2021-2032) & (K Units) Figure 5. Global Basal Insulin (Long-Acting Insulin) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Basal Insulin (Long-Acting Insulin) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Basaglar Image Figure 9. Lantus Image Figure 10. Levemir Image Figure 11. Biosimilar Glargines Image Figure 12. Toujeo Image Figure 13. Tresiba Image Figure 14. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Basal Insulin (Long-Acting Insulin) Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2021-2032) Figure 17. Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2021-2032) Figure 20. Type 1 Diabetes Image Figure 21. Type 2 Diabetes Image Figure 22. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Basal Insulin (Long-Acting Insulin) Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2021-2032) Figure 25. Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2021-2032) Figure 28. North America Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2021-2032) Figure 30. U.S. Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2021-2032) Figure 35. Germany Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2021-2032) Figure 42. China Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share by Country (2021-2032) Figure 50. Brazil Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Basal Insulin (Long-Acting Insulin) Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Basal Insulin (Long-Acting Insulin) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Figure 61. North America Basal Insulin (Long-Acting Insulin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Figure 63. Europe Basal Insulin (Long-Acting Insulin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Basal Insulin (Long-Acting Insulin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Basal Insulin (Long-Acting Insulin) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Basal Insulin (Long-Acting Insulin) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Basaglar
  • Lantus
  • Levemir
  • Biosimilar Glargines
  • Toujeo
  • Tresiba
Applications
  • Type 1 Diabetes
  • Type 2 Diabetes
Companies covered
  • Wockhardt
  • Eli Lilly
  • Julphar
  • Sedico
  • Sanofi Aventis
  • Novo Nordisk
  • Exir
  • Biocon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Basal Insulin (Long-Acting Insulin) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Basal Insulin (Long-Acting Insulin) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Basal Insulin (Long-Acting Insulin) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Basal Insulin (Long-Acting Insulin) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Basal Insulin (Long-Acting Insulin) Market Dynamics
  1. 2.1 Basal Insulin (Long-Acting Insulin) Industry Trends
  2. 2.2 Basal Insulin (Long-Acting Insulin) Industry Drivers
  3. 2.3 Basal Insulin (Long-Acting Insulin) Industry Opportunities and Challenges
  4. 2.4 Basal Insulin (Long-Acting Insulin) Industry Restraints
3 Basal Insulin (Long-Acting Insulin) Market by Manufacturers
  1. 3.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Basal Insulin (Long-Acting Insulin) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Basal Insulin (Long-Acting Insulin) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Basal Insulin (Long-Acting Insulin) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Basal Insulin (Long-Acting Insulin) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Basal Insulin (Long-Acting Insulin) Manufacturers, Product Type & Application
  7. 3.7 Global Basal Insulin (Long-Acting Insulin) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Basal Insulin (Long-Acting Insulin) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Basal Insulin (Long-Acting Insulin) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Basal Insulin (Long-Acting Insulin) Tier 1, Tier 2, and Tier 3
4 Basal Insulin (Long-Acting Insulin) Market by Type
  1. 4.1 Basal Insulin (Long-Acting Insulin) Type Introduction
  2. 4.1.1 Basaglar
  3. 4.1.2 Lantus
  4. 4.1.3 Levemir
  5. 4.1.4 Biosimilar Glargines
  6. 4.1.5 Toujeo
  7. 4.1.6 Tresiba
  8. 4.2 Global Basal Insulin (Long-Acting Insulin) Sales by Type
  9. 4.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Basal Insulin (Long-Acting Insulin) Sales by Type (2021-2032)
  11. 4.2.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type (2021-2032)
  12. 4.3 Global Basal Insulin (Long-Acting Insulin) Revenue by Type
  13. 4.3.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Type (2021-2032)
  15. 4.3.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Type (2021-2032)
5 Basal Insulin (Long-Acting Insulin) Market by Application
  1. 5.1 Basal Insulin (Long-Acting Insulin) Application Introduction
  2. 5.1.1 Type 1 Diabetes
  3. 5.1.2 Type 2 Diabetes
  4. 5.2 Global Basal Insulin (Long-Acting Insulin) Sales by Application
  5. 5.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Basal Insulin (Long-Acting Insulin) Sales by Application (2021-2032)
  7. 5.2.3 Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application (2021-2032)
  8. 5.3 Global Basal Insulin (Long-Acting Insulin) Revenue by Application
  9. 5.3.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Application (2021-2032)
  11. 5.3.3 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Application (2021-2032)
6 Global Basal Insulin (Long-Acting Insulin) Sales by Region
  1. 6.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Basal Insulin (Long-Acting Insulin) Sales by Region (2021-2032)
  3. 6.2.1 Global Basal Insulin (Long-Acting Insulin) Sales by Region (2021-2026)
  4. 6.2.2 Global Basal Insulin (Long-Acting Insulin) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Basal Insulin (Long-Acting Insulin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Basal Insulin (Long-Acting Insulin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Basal Insulin (Long-Acting Insulin) Revenue by Region
  1. 7.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Region
  2. 7.1.1 Global Basal Insulin (Long-Acting Insulin) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2021-2026)
  4. 7.1.3 Global Basal Insulin (Long-Acting Insulin) Revenue by Region (2027-2032)
  5. 7.1.4 Global Basal Insulin (Long-Acting Insulin) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Basal Insulin (Long-Acting Insulin) Revenue (2021-2032)
  8. 7.2.2 North America Basal Insulin (Long-Acting Insulin) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Basal Insulin (Long-Acting Insulin) Revenue (2021-2032)
  11. 7.3.2 Europe Basal Insulin (Long-Acting Insulin) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Basal Insulin (Long-Acting Insulin) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Basal Insulin (Long-Acting Insulin) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Basal Insulin (Long-Acting Insulin) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Wockhardt
  2. 8.1.1 Wockhardt Company Information
  3. 8.1.2 Wockhardt Business Overview
  4. 8.1.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wockhardt Basal Insulin (Long-Acting Insulin) Product Portfolio
  6. 8.1.5 Wockhardt Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Julphar
  14. 8.3.1 Julphar Company Information
  15. 8.3.2 Julphar Business Overview
  16. 8.3.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Julphar Basal Insulin (Long-Acting Insulin) Product Portfolio
  18. 8.3.5 Julphar Recent Developments
  19. 8.4 Sedico
  20. 8.4.1 Sedico Company Information
  21. 8.4.2 Sedico Business Overview
  22. 8.4.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sedico Basal Insulin (Long-Acting Insulin) Product Portfolio
  24. 8.4.5 Sedico Recent Developments
  25. 8.5 Sanofi Aventis
  26. 8.5.1 Sanofi Aventis Company Information
  27. 8.5.2 Sanofi Aventis Business Overview
  28. 8.5.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product Portfolio
  30. 8.5.5 Sanofi Aventis Recent Developments
  31. 8.6 Novo Nordisk
  32. 8.6.1 Novo Nordisk Company Information
  33. 8.6.2 Novo Nordisk Business Overview
  34. 8.6.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Product Portfolio
  36. 8.6.5 Novo Nordisk Recent Developments
  37. 8.7 Exir
  38. 8.7.1 Exir Company Information
  39. 8.7.2 Exir Business Overview
  40. 8.7.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Exir Basal Insulin (Long-Acting Insulin) Product Portfolio
  42. 8.7.5 Exir Recent Developments
  43. 8.8 Biocon
  44. 8.8.1 Biocon Company Information
  45. 8.8.2 Biocon Business Overview
  46. 8.8.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Biocon Basal Insulin (Long-Acting Insulin) Product Portfolio
  48. 8.8.5 Biocon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Basal Insulin (Long-Acting Insulin) Value Chain Analysis
  2. 9.1.1 Basal Insulin (Long-Acting Insulin) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Basal Insulin (Long-Acting Insulin) Production Mode & Process
  6. 9.2 Basal Insulin (Long-Acting Insulin) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Basal Insulin (Long-Acting Insulin) Distributors
  9. 9.2.3 Basal Insulin (Long-Acting Insulin) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst